Xanthine oxidase inhibitors: a patent survey

Bibliography

• Harrison R. Structure and function of xanthine oxidoreductase: where are we now? Free Radic Biol Med 2002;21:774-97
   Google Scholar
• Nishino T, Okamoto K, Eger BT, Mammalian xanthine oxidoreductase: mechanism of transition from xanthine dehydrogenase to xanthine oxidase. FEBS J 2008;275:3278-89
   PubMed Web of Science ®Google Scholar
• Stockert AL, Shinde SS, Anderson RF, The reaction mechanism of xanthine oxidase: evidence for two-electron chemistry rather than sequential one-electron steps. J Am Chem Soc 2002;124:14554
   PubMed Web of Science ®Google Scholar
• Borges F, Fernandes E, Roleira F. Progress Towards the Discovery of Xanthine Oxidase Inhibitors. Curr Med Chem 2002;9:195-217
   PubMed Web of Science ®Google Scholar
• Hille R. Structure and function of xanthine oxidoreductase. Eur J Inorg Chem 2006;1913-24
   Google Scholar
• Pacher P, Nivorozhkin A, Szabo C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev 2006;58:87-114
   PubMed Web of Science ®Google Scholar
• Elion GB, Callahan S, Nathan H, Potentiation by inhibition of drug degradation: 6-Substituted purines and xanthine oxidase. Biochem Pharmacol 1963;12:85
   Web of Science ®Google Scholar
• Massey V, Komai H, Palmer G. On the mechanism of inactivation of xanthine oxidase by allopurinol and other pyrazolo[3,4-d]pyrimidines. J Bio Chem 1970;245:2837-44
   PubMed Web of Science ®Google Scholar
• Krakoff IH. Use of allopurinol in preventing hyperuricemia in leukemia and lymphoma. Cancer 1966;19:1489-96
   PubMed Web of Science ®Google Scholar
• Tamta H, Thilagavathi R, Chakraborti AK, 6-(N-Benzylamino)purine as a novel and potent inhibitor of xanthine oxidase: inhibition mechanism and molecular modeling studies. J Enzyme Inhib Mol Chem 2005;20:317-24
   PubMed Web of Science ®Google Scholar
• Hillo R, Stewart RC. The inhibition of xanthine oxidase by 8-Bromoxanthines. J Biol Chem 1984;259:1570-6
   Google Scholar
• Gupta S, Rodrigues LM, Esteves AP, Synthesis of N-Aryl-5-amino-4-cyanopyrazole derivatives as potent xanthine oxidase inhibitors. Eur J Med Chem 2008;43:771-80
   PubMed Web of Science ®Google Scholar
• Biagi G, Giorgi I, Pacchini F, 2-Alkyloxyalkylthiohypoxanthines as new potent inhibitors of xanthine oxidase. IL Pharmaco 2001;56:809-13
   Google Scholar
• Robins RK, Revankar GR, O'Brien DE, Purine analog inhibitors of xanthine oxidase-structure activity relationships and proposed binding of the molybdenum cofactor. J Heterocycl Chem 1985;22:601-34
   Web of Science ®Google Scholar
• Oettl K, Reibneggar G. Pteridines as inhibitors of xanthine oxidase: structural requirements. Biochim Biophys Acta 1999;1430:387-95
   PubMed Web of Science ®Google Scholar
• Arai T, Endo N, Yamashita K, A xanthine oxidase inhibitor, intracellularly generates reactive oxygen species involved in apoptosis and cell proliferation. Free Radical Biol Med 2001;30:248-59
   PubMed Web of Science ®Google Scholar
• Kalra S, Jena G, Tikoo K, Preferential inhibition of xanthine oxidase by 2-amino-6-hydroxy-8-mercaptopurine and 2-amino-6-purinethiol. BMC Biochem 2007;8:1471-82
   Google Scholar
• Hsieh JF, Wu SH, Yang YL, The screening and characterization of 6-aminopurine based xanthine oxidase inhibitors. Bioorg Med Chem 2007;15:3450-6
   PubMed Web of Science ®Google Scholar
• Nagamatsu T, Fujita T, Endo K. Convenient and general syntheses of 3-substituted 7H-Pyrazolo[4,3-e]-1,2,4-triazolo[4,3-c]pyrimidin-5(6H)-ones as a new class of potential xanthine oxidase inhibitors. Perkin 2000;1:33
   Google Scholar
• Nagamatsu T, Ukai M, Yoneda F, Syntheses of 4-Methyl-s-triazolo [4, 3-a] purin-9 (4H)-ones and Tetrazolo-[1, 5-a] purin-9 (4H)-ones as Aza Analogs of “Y”Bases. Chem Pharm Bull 1985;33:3113
   Web of Science ®Google Scholar
• Nagamatsu T, Yamasaki H. General and productive syntheses of the fluorescent dye (4,9- Dihydro-4,6-dimethyl-9-oxo-1H-imidazo(1,2-a)purine) in phenylalanine tRNA, Its 2-substituted derivatives and 7-Aza Analogues. J Chem Soc Chem Commun 1995;19:2041
   Google Scholar
• Nagamatsu T, Yamasaki H, Akiyama T, Facile and general syntheses of 3- and/or 5-Substituted 7-beta-D-Ribofuranosyl-7H-[1,2,4]triazolo[3,4-i]purines as a new class of potential xanthine oxidase inhibitors. Synthesis 1999;4:655
   Google Scholar
• Nagamatsu T, Fujita T. A comparative study of AutoDock and PMF scoring performances, and SAR of 2-substituted pyrazolotriazolopyrimidines and 4-substituted pyrazolopyrimidines as potent xanthine oxidase inhibitor. Chem Commun (Cambridge) 1999;16:1461
   Google Scholar
• Ali HI, Fujita T, Akaho E, Nagamatsu T. A comparative study of AutoDock and PMF scoring performances, and SAR of 2-substituted pyrazolotriazolopyrimidines and 4-substituted pyrazolopyrimidines as potent xanthine oxidase inhibitor. J Comput Aided Mol Des 2010;24:57
   PubMed Web of Science ®Google Scholar
• Gonzalez AG, Bazzocchi IL, Moujir L, Xanthine oxidase inhibitory activity of some panamanian plants from celastraceae and lamiaceae. J Ethnopharmacol 1995;46:25-9
   PubMedGoogle Scholar
• Owen PL, Johns T. Xanthine oxidase inhibitory activity of northeastern north american plant remedies used for gout. J Ethnopharmacol 1999;64:149-60
   PubMed Web of Science ®Google Scholar
• Liu X, Chen R, Shang Y, Lithospermic acid as a novel xanthine oxidase inhibitor has anti-inflammatory and hypouricemic effects in rats. Chem Biol Interact 2008;176:137-42
   PubMed Web of Science ®Google Scholar
• Noro T, Oda Y, Miyase T, Inhibitors of xanthine oxidase from the flowers and buds of dafne genkwa. Chem Pharm Bull 1983;31:3984-7
   PubMed Web of Science ®Google Scholar
• Kong LD, Cai Y, Huang WW, Inhibition of xanthine oxidase by some chinese medicinal plants used to treat gout. J Ethnopharmacol 2000;73:199-207
   PubMed Web of Science ®Google Scholar
• Shen L, Ji HF. Insights into the inhibition of xanthine oxidase by curcumin. Bioorg Med Chem Lett 2009;19:5990-3
   PubMed Web of Science ®Google Scholar
• Chang YC, Lee FW, Chen CS, Structure-activity relationship of c6-c3 phenylpropanoids on xanthine oxidase inhibitory and free radical-scavenging activities. Free Radical Biol Med 2007;43:1541-51
   PubMed Web of Science ®Google Scholar
• Umamaheswari M, Kumar KA, Somasundarum A, Xanthine oxidase inhibitory activity of some indian medicinal plants. J Ethnopharmcol 2007;109:547-51
   PubMed Web of Science ®Google Scholar
• Jiao RH, Ge HM, Shi DH, An apigenin derived xanthine oxidase inhibitor from palhinhaea cernua. J Nat Prod 2006;69:1089-91
   Google Scholar
• Wang SY, Yang CW, Liao JW, Essential oil from leaves of cinnamomum osmophloeum acts as a xanthine oxidase inhibitor and reduces the serum uric acid levels in oxonate-induced mice. Phytomedicine 2008;15:940-5
   PubMed Web of Science ®Google Scholar
• Rastelli G, Costantino L, Albasini A. Theoretical and experimental study of flavones as inhibitors of xanthine oxidase. Eur J Med Chem 1995;30:141-6
   Google Scholar
• Costantino L, Rastelli G, Albasini A. A Rational approach to the design of flavones as xanthine oxidase inhibitors. Eur J Med Chem 1996;31:693-9
   Google Scholar
• Lin CM, Chen CS, Chen CT, Molecular modeling of flavonoids that inhibits xanthine oxidase. Biochem Biophys Res Commun 2002;294:167-72
   PubMed Web of Science ®Google Scholar
• Hoorn DECV, Nijveldt RJ, Leeuwen PAMV, Accurate prediction of xanthine oxidase inhibition based on the structure of flavonoids. Eur J Phrmacol 2002;451:111-18
   PubMed Web of Science ®Google Scholar
• Da Silva SL, Da Silva A, Honorio KM, The Influence of electronic, steric and hydrophobic properties of flavonoid compounds in the inhibition of the xanthine oxidase. J Mol Struct Theochem 2004;684:1-7
   Web of Science ®Google Scholar
• Ferrari AM, Sgobba M, Gamberini MC, Relationship between quantum-chemical descriptors of proton dissociation and experimental activity constants of various hydroxylated coumarins, identification of biologically active species for xanthine oxidase inhibition. Eur J Med Chem 2007;42:1028-31
   PubMed Web of Science ®Google Scholar
• Lin HC, Tsai SH, Chen CS, Structure-activity relationship of coumarin derivatives on xanthine oxidase-inhibiting and free radical-scavenging activities. Biochem Pharmacol 2008;75:1416-25
   PubMed Web of Science ®Google Scholar
• Silva MP, Mira L, Lima J, Kinetics of the inhibition of xanthine dehydrogenase and of the reversible and irreversible form of xanthine oxidase by silibinin and bendazac. Environ Toxicol Pharmacol 1996;1:279-84
   Google Scholar
• Muraoka S, Miura T. Inhibition of xanthine oxidase by phytic acid and its antioxidant action. Life Sci 2004;74:1691-700
   Google Scholar
• Mashino T, Takigawa Y, Saito N, Antioxidant activity and xanthine oxidase inhibition activity of reductic acid: ascorbic acid analogue. Bioorg Med Chem Lett 2000;10:2783-5
   Google Scholar
• Chaves S, Gil M, Canario S, Biologically relevant O,S-donor compounds. synthesis, molybdenum complexation and xanthine oxidase inhibition. Dalton Trans 2008:1773-82
   Google Scholar
• You ZL, Shi DH, Zhu HL. The Inhibition of xanthine oxidase by the schiff base zinc (II) complex. Inorg Chem Commun 2006;9:642-4
   Web of Science ®Google Scholar
• You ZL, Shi DH, Xu C, Schiff base transition metal complexes as novel inhibitors of xanthine oxidase. Eur J Med Chem 2008;43:862-71
   PubMed Web of Science ®Google Scholar
• Li YG, Shi DH, Zhu HL, Transition metal complexes (M= Cu, Ni, and Mn) of schiff-base ligands: synthesis, crystal structures, and inhibitory bioactivities against urease and xanthine oxidase. Inorg Chim Acta 2007;360:2881-9
   Web of Science ®Google Scholar
• Maitraie D, Hung CF, Tu HY, Synthesis, anti-inflammatory, and antioxidant activities of 18beta-glycyrrhetinic acid derivatives as chemical mediators and xanthine oxidase inhibitors. Biorg Med Chem 2009;17:2785-92
   PubMed Web of Science ®Google Scholar
• Olivera-Campos AMF, Sivasubramanian A, Rodrigues LM, Substituted Pyrazolo[3,4-d]pyrimidines: microwave-assisted, solvent-free synthesis and biological evaluation. Helv Chim Acta 2008;91:1336-45
   Google Scholar
• Yu KH. Febuxostat: a novel non-purine selective inhibitor of xanthine oxidase for the treatment of hyperuricemia in gout. Recent Pat Inflamm Allergy Drug Discov 2007;1:69-75
   PubMedGoogle Scholar
• Galbusera C, Orth P, Fedida D, Superoxide radical production by Allopurinol and Xanthine oxidase. Biochem Pharmacol 2006;71:1747-52
   PubMedGoogle Scholar
• Ishibuchi S, Morimoto H, Oe T, Synthesis and structure-activity relationship of 1-phenylpyrazoles as xanthine oxidase inhibitors. Biorg Med Chem Lett 2001;11:879-82
   PubMed Web of Science ®Google Scholar
• Fukunari A, Okamoto K, Nishino T, Y-700 [1-[3-Cyano-4-(2,2-dimethylpropoxy)phenyl]-1H-pryazole-4-carboxylic acid]: a potent xanthine oxidoreductase inhibitor with hepatic excretion. J Pharmacol Exp Ther 2004;311:519-28
   PubMed Web of Science ®Google Scholar
• Prusis P, Dambrova M, Andrianov V, Synthesis and quantitative structure-activity relationship of hydrazones of N-Amino-N-hydroxyguanidine as electron acceptors for xanthine oxidse. J Med Chem 2004;47:3105-10
   PubMed Web of Science ®Google Scholar
• Wang S, Yan J, Wang J, Synthesis of some 5-Phenylisoxazole-3-carboxylic acid derivatives as potent xanthine inhibitors. Eur J Med Chem 2010;45:2663-70
   PubMed Web of Science ®Google Scholar
• Nakamura H, Ono A, Sato T, Fuji Yaku Hin Co., Ltd., Japan. Jpn Kokai Tokkyo Koho 2005;10
   Google Scholar
• Okamoto K, Matsumoto K, Hille R, The crystal structure of xanthine oxidoreductase during catalysis: implications for reaction mechanism and enzyme inhibition. Proc Natl Acad Sci USA 2004;101:7931-6
   PubMed Web of Science ®Google Scholar
• Nepali K, Singh G, Turan A, A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitors. Bioorg Med Chem 2011;19:1950-8
   PubMed Web of Science ®Google Scholar
• ICN Pharmaceuticals, Inc., Irvine, Calif. Xanthine oxidase inhibitors. US003907799; 1975
   Google Scholar
• BTG International Ltd, 5 Fleet Place, London UK. Use of xanthine oxidase inhibitors as anti ischaemic agents. US006004966A; 1999
   Google Scholar
• Yamasa Corp., Chiba, Japan. Purine compounds and xanthine oxidase inhibitors. US005990118; 1999
   Google Scholar
• Fisons Ltd, Ipswich, England. Methods of lowering Plasma uric acid levels. US003988469; 1976
   Google Scholar
• Pierre Fabre S.A., Paris, France. Method of treating Hyperuricemia and Gout. US004271191; 1981
   Google Scholar
• Siegfried Aktiengesellschaft, Switzerland. Xanthine oxidase inhibitor and therapeutic treatment using same. US004305942; 1981
   Google Scholar
• Ludwig Merckle K.G., Chem. Pharm. Fabrik, Rep. of Germany. Treatment of hyperuricaemia with etofylline clofibrate. US004246264; 1981
   Google Scholar
• Eli Lilly and Co., Indianapolis, Ind. Xanthine oxidase inhibiting 3(5)-Phenyl-substituted-5(3)-Pyrazole-carboxylicacid derivatives, compositions, and methods of use. US004495195; 1985
   Google Scholar
• Boehringer Ingelheim international GMBH[DE/DE]; Postfach 200, D-6507 Ingelheim (DE) Oxoquinazoline derivatives used as xanthine oxidase inhibitors and their application in the case of ischemia. WO9008546; 1990
   Google Scholar
• Gunze Ltd, Kyoto, Medical division (Kyoto), Japan. Xanthine oxidase inhibitor. US005212201; 1993
   Google Scholar
• Teijin Ltd, Osaka, Japan. 2-Arylthiazole derivatives and pharmaceutical composition thereof. US005614520A; 1997
   Google Scholar
• Knoll Aktiengesellschaft, Ludwigshafen, Germany. Medical treatment to lower uric acid levels. US006162831A; 2000
   Google Scholar
• Ito En, Ltd., Tokyo (JP). Xanthine oxidase inhibitor and method of producing the same. US006589573B2; 2003
   Google Scholar
• Unno T, Sugimoto A, Kakuda T. Xanthine oxidase inhibitors from the leaves of lagerstroemia speciosa (L.) Pers J Ethnopharmacol 2004;93:391-5
   PubMed Web of Science ®Google Scholar
• Astellas pharma, Inc. [JP/JP]; 1038411 Tokyo (JP). Remedy or preventive for digestive ulcer. WO2007097403A1; 2007
   Google Scholar
• Nippon Chemiphar Co., Ltd., Tokyo (JP). Substituted thiazolopyrimidines as xanthine oxidase inhibitors. US007253154; 2007
   Google Scholar
• Astellas pharma, Inc. [JP/JP]; 1038411 Tokyo (JP). Therapeutic agent for Hypertension. WO2008126772A1; 2008
   Google Scholar
• Nippon Chemiphar Co., Ltd., Chiyoda – Ku, Tokyo (JP). Substituted 1,3 – Thiazolo[5,4-D]Pyrimidines as Xanthine oxidase inhibitors. US007598254; 2009
   Google Scholar
• LG Life Sciences Ltd. [KR/KR]; East Tower, LG Twin Tower, 20, Yoido-Dong, Youngdeungpo-gu, Seoul 150-010 (KR). novel compounds effective as xanthine oxidase inhibitors, methods for preparing the same, and pharmaceutical composition containing the same. WO2010093191; 2010
   Google Scholar
• Okamoto K, Kawaguchi Y, Eger BT, Crystal structures of urate bound form of xanthine oxidoreductase: substrate orientation and structure of the key reaction intermediate. J Am Chem Soc 2010;132:17080-3
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Okamoto K, Ashizawa N, FYX-051: a novel and potent hybrid-type inhibitor of xanthine oxidoreductase. J Pharmacol Exp Ther 2011;336:95-103
   Google Scholar
• Cao H, Pauff JM, Hille R. Substrate orientation and catalytic specificity in the action of xanthine oxidase .the sequential hydroxylation of hypoxanthine to uric acid. J Biol Chem 2010;285:28044-53
   PubMed Web of Science ®Google Scholar
• Thapper A, Boer DR, Brondino CD, Correlating EPR and X-ray structural analysis of arsenite-inhibited forms of aldehyde oxidoreductase. J Biol Inorg Chem 2007;12:353-66
   Google Scholar
• Dietzel U, Kuper J, Doebbler JA, Mechanism of substrate and inhibitor binding of rhodobacter capsulatus xanthine dehydrogenase. J Biol Chem 2009;284:8768-76
   Google Scholar
• Okamoto K, Eger BT, Nishino T, Mechanism of inhibition of xanthine oxidoreductase by allopurinol: crystal structure of reduced bovine milk xanthine oxidoreductase bound with oxipurinol. Nucleosides Nucleotides Nucleic Acids 2008;27:888-93
   PubMed Web of Science ®Google Scholar
• Gabison L, Prange T, Colloch N, Structural analysis of urate oxidase in complex with its natural substrate inhibited by cyanide: mechanistic implications. Bmc Struct Biol 2008;8:32
   PubMed Web of Science ®Google Scholar
• Pauff JM, Zhang J, Bell CE, Substrate orientation in xanthine oxidase. Crystal structure of enzyme in reaction With 2-Hydroxy-6-Methylpurine. J Biol Chem 2008;283:4818-24
   Google Scholar
• Fukunari A, Okamoto K, Nishino T, Y-700 [1-[3-Cyano-4-(2,2-dimethylpropoxy)phenyl]-1H-pyrazole-4-carboxylic Acid]: a potent xanthine oxidoreductase inhibitor with hepatic excretion. J Pharmacol Exp Ther 2004;311:519-28
   PubMed Web of Science ®Google Scholar
• Okamoto K, Eger BT, Nishino T, An extremely potent inhibitor of xanthine oxidoreductase. crystal structure of the enzyme-inhibitor complex and mechanism of inhibition. J Biol Chem 2003;278:1848-55
   PubMed Web of Science ®Google Scholar
• Enroth C, Eger BT, Okamoto K, Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: structure-based mechanism of conversion. Proc Natl Acad Sci USA 2000;97:10723-8
   PubMed Web of Science ®Google Scholar
• Truglio JJ, Theis K, Leimkuhler S, Crystal structures of the active and alloxanthine-inhibited forms of xanthine dehydrogenase from Rhodobacter capsulatus. Structure 2002;10:115-25
   PubMed Web of Science ®Google Scholar